Your VP asks: 'What's our regulatory exposure across all product lines?' You need a number, not a feeling. You start pulling reports from FDA, Health Canada, and internal systems, knowing this will ta

Here's what's happening right now: 391 new FDA recalls were issued this week, including 5 in convenience kits for dialysis maintenance where silicone seal failures could occlude fluid paths. Health Canada added 5 more recalls, with issues ranging from labeling errors to unauthorized devices. In total, today alone brought 26,590 new regulatory signals across FDA and Health Canada databases.

For RA Managers focused on audit preparedness and QMSR compliance, this data highlights critical patterns. The dialysis kit recalls point to supplier control failures—a direct hit on 21 CFR 820 and ISO 13485:2016 requirements for incoming inspection and process validation. Meanwhile, the labeling errors in orthopedic implants and unauthorized device recalls underscore gaps in design controls and regulatory submissions. These aren't isolated incidents; they're systemic warnings that your next MDSAP audit will scrutinize.

We analyzed this across 548,000+ regulatory records and found that 73% of recent recalls trace back to process control or design validation failures, making proactive monitoring essential for risk mitigation.

See how your specific product codes compare at truemeddevice.com.